Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features

International Journal of Environmental Research and Public Health

Volumn 6, Issue 7, 2009, Pages 1980-1990

  Drago, Antonio ^a   Liappas, Ioannis ^b   Petio, Carmine ^a,g   Albani, Diego ^c   Forloni, Gianluigi ^c   Malitas, Petros ^d   Piperi, Christina ^e   Politis, Antonis ^b   Tzavellas, Elias O ^b   Zisaki, Katerina K ^e   Prato, Francesca ^c   Batelli, Sara ^c   Polito, Letizia ^c   De Ronchi, Diana ^a   Paparrigopoulos, Thomas ^b   Kalofoutis, Anastasios ^d,e,f   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d European Centre for the Quality of Life ECQuaL   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^g Azienda USL di Bologna   (Italy)

Author keywords

5HTPR; Alcohol dependence; Association; Gene; HTR2A; IL1A; IL1B; TNF; TPH2

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; SERINE PROTEINASE OMI; SEROTONIN TRANSPORTER; TUMOR NECROSIS FACTOR;

ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE LOCATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY;

ADULT; ALCOHOLISM; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC VARIATION; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68149087761     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6071980     Document Type: Article

References (43)

1. Serretti, A.; Artioli, P. The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenomics J. 2004, 4, 233-244.
2. Fisher, P.M.; Munoz, K.E.; Hariri, A.R. Identification of neurogenetic pathways of risk for psychopathology. Am. J. Med. Genet. C Semin. Med. Genet. 2008, 2, 147-153.
3. D'Souza, U.M.; Craig, I.W. Functional polymorphisms in dopamine and serotonin pathway genes. Hum. Mutat. 2006, 1, 1-13.
4. Lesch, K.P. Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link? Eur. J. Pharmacol. 2005, 1, 113-124.
5. Vengeliene, V.; Bilbao, A.; Molander, A.; Spanagel, R. Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 2008, 2, 299-315.
6. Serretti, A.; Calati, R.; Mandelli, L.; de Ronchi, D. Serotonin transporter gene variants and behavior: a comprehensive review. Curr. Drug Target. 2006, 12, 1659-1669.
7. Pinto, E.; Reggers, J.; Gorwood, P.; Boni, C.; Scantamburlo, G.; Pitchot, W.; Ansseau, M. The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol Alcoholism 2008, 4, 398-400.
8. Dick, D.M.; Plunkett, J.; Hamlin, D.; Nurnberger, J., Jr.; Kuperman, S.; Schuckit, M.; Hesselbrock, V.; Edenberg, H.; Bierut, L. Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Psychiatr. Genet. 2007, 1, 35-38.
9. Marques, F.Z.; Hutz, M.H.; Bau, C.H. Influence of the serotonin transporter gene on comorbid disorders among alcohol-dependent individuals. Psychiatr. Genet. 2006, 3, 125-131.
10. Kohnke, M.D.; Kolb, W.; Lutz, U.; Maurer, S.; Batra, A. The serotonin transporter promotor polymorphism 5-HTTLPR is not associated with alcoholism or severe forms of alcohol withdrawal in a German sample. Psychiatr. Genet. 2006, 6, 227-228.
11. Rasmussen, H.; Bagger, Y.; Tanko, L.B.; Christiansen, C.; Werge, T. Lack of association of the serotonin transporter gene promoter region polymorphism, 5-HTTLPR, including rs25531 with cigarette smoking and alcohol consumption. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150, 575-580.
12. Serretti, A.; Drago, A.; De Ronchi, D. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr. Med. Chem. 2007, 19, 2053-2069.
13. Polina, E.R.; Contini, V.; Hutz, M.H.; Bau, C.H. The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug Alcohol Depend. 2009, 1, 128-131.
14. Hwu, H.G.; Chen, C.H. Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am. J. Med. Genet. 2000, 6, 797-800.
15. Nakamura, T.; Matsushita, S.; Nishiguchi, N.; Kimura, M.; Yoshino, A.; Higuchi, S. Association of a polymorphism of the 5HT2A receptor gene promoter region with alcohol dependence. Mol. Psychiat. 1999, 1, 85-88.
16. Himmerich, H.; Fulda, S.; Linseisen, J.; Seiler, H.; Wolfram, G.; Himmerich, S.; Gedrich, K.; Kloiber, S.; Lucae, S.; Ising, M.; Uhr, M.; Holsboer, F.; Pollmacher, T. Depression, comorbidities and the TNF-alpha system. Eur. Psychiat. 2008, 6, 421-429.
17. Zill, P.; Preuss, U.W.; Koller, G.; Bondy, B.; Soyka, M. SNP- and haplotype analysis of the tryptophan hydroxylase 2 gene in alcohol-dependent patients and alcohol-related suicide. Neuropsychopharmacology 2007, 8, 1687-1694.
18. Mokrovic, G.; Matosic, A.; Hranilovic, D.; Stefulj, J.; Novokmet, M.; Oreskovic, D.; Balija, M.; Marusic, S.; Cicin-Sain, L. Alcohol dependence and polymorphisms of serotonin-related genes: association studies. Coll. Antropol. 2008, 32, 127-131.
19. Gacek, P.; Conner, T.S.; Tennen, H.; Kranzler, H.R.; Covault, J. Tryptophan hydroxylase 2 gene and alcohol use among college students. Addict. Biol. 2008, 3, 440-448.
20. Yu, Y.W.; Chen, T.J.; Hong, C.J.; Chen, H.M.; Tsai, S.J. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003, 6, 1182-1185.
21. Pastor, I.J.; Laso, F.J.; Romero, A.; Gonzalez-Sarmiento, R. Interleukin-1 gene cluster polymorphisms and alcoholism in Spanish men. Alcohol Alcoholism 2005, 3, 181-186.
22. Serretti, A.; Liappas, I.; Mandelli, L.; Albani, D.; Forloni, G.; Malitas, P.; Piperi, C.; Zisaki, A.; Tzavellas, E.O.; Papadopoulou-Daifoti, Z.; Prato, F.; Batelli, S.; Pesaresi, M.; Kalofoutis, A. Interleukin-1 alpha and beta, TNF-alpha and HTTLPR gene variants study on alcohol toxicity and detoxification outcome. Neurosci. Lett. 2006, 1, 107-112.
23. Serretti, A.; Liappas, I.; Mandelli, L.; Albani, D.; Forloni, G.; Malitas, P.; Piperi, C.; Politis, A.; Tzavellas, E.O.; Papadopoulou-Daifoti, Z.; Zisaki, A.; Prato, F.; Batelli, S.; Polito, L.; De Ronchi, D.; Kalofoutis, A. TPH2 gene variants and anxiety during alcohol detoxification outcome. Psychiat. Res. 2009, 1, 106-114.
24. Wing, J.K.; Babor, T.; Brugha, T.; Burke, J.; Cooper, J.E.; Giel, R.; Jablenski, A.; Regier, D.; Sartorius, N. SCAN, schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiat. 1990, 6, 589-593.
25. Ye, J.; Wang, L.; Zhang, X.; Tantishaiyakul, V.; Rojanasakul, Y. Inhibition of TNF-alpha gene expression and bioactivity by site-specific transcription factor-binding oligonucleotides. Am. J. Physiol. Lung Cell Mol. Physiol. 2003, 2, L386-L394.
26. Liebowitz, M.R. Social phobia. Mod. Probl. Pharm. 1987, 22, 141-173.
27. Marks, I.M.; Mathews, A.M. Brief standard self-rating for phobic patients. Behav. Res. Ther. 1979, 3, 263-267.
28. Cooper, J.E. The Leyton Obsessional Inventory. Psychol. Med. 1970, 1, 48-64.
29. Pilowsky, I. Dimensions of hypochondriasis. Br. J. Psychiat. 1967, 494, 89-93.
30. Lou, X.Y.; Chen, G.B.; Yan, L.; Ma, J.Z.; Zhu, J.; Elston, R.C.; Li, M.D. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 2007, 6, 1125-1137.
31. Drago, A.; de Ronchi, D.; Serretti, A. Incomplete coverage of candidate genes: a poorly considered bias. Curr. Genomics 2007, 7, 476-483.
32. Walther, D.J.; Peter, J.U.; Bashammakh, S.; Hortnagl, H.; Voits, M.; Fink, H.; Bader, M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299, 76.
33. Zill, P.; Baghai, T.C.; Zwanzger, P.; Schule, C.; Eser, D.; Rupprecht, R.; Moller, H.J.; Bondy, B.; Ackenheil, M. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiat. 2004, 11, 1030-1036.
34. Zhou, Z.; Peters, E.J.; Hamilton, S.P.; McMahon, F.; Thomas, C.; McGrath, P.J.; Rush, J.; Trivedi, M.H.; Charney, D.S.; Roy, A.; Wisniewski, S.; Lipsky, R.; Goldman, D. Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16.
35. Neuron 2005, 48, 704-705; author reply 705-706.
36. Zhou, Z.; Roy, A.; Lipsky, R.; Kuchipudi, K.; Zhu, G.; Taubman, J.; Enoch, M.A.; Virkkunen, M.; Goldman, D. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch. Gen. Psychiat. 2005, 10, 1109-1118.
37. Harvey, M.; Shink, E.; Tremblay, M.; Gagne, B.; Raymond, C.; Labbe, M.; Walther, D.J.; Bader, M.; Barden, N. Support for the involvement of TPH2 gene in affective disorders. Mol. Psychiat. 2004, 11, 980-981.
38. de Luca, V.; Likhodi, O.; van Tol, H.H.; Kennedy, J.L.; Wong, A.H. Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berl) 2005, 3, 378-382.
39. Hoebel, B.G.; Hernandez, L.; McClelland, R.C.; Schwartz, D. Dexfenfluramine and feeding reward. Clin. Neuropharmacol. 1988, 11, S72-S85.
40. Jadhav, S.A.; Gaikwad, R.V.; Gaonkar, R.K.; Thorat, V.M.; Gursale, S.C.; Balsara, J.J. Dose-dependent response of central dopaminergic systems to buspirone in mice. Indian J. Exp. Biol. 2008, 10, 704-714.
41. Urwin, R.E.; Nunn, K.P. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. Eur. J. Hum. Genet. 2005, 3, 370-375.
42. van Gestel, S.; Forsgren, T.; Claes, S.; Del-Favero, J.; van Duijn, C.M.; Sluijs, S.; Nilsson, L.G.; Adolfsson, R.; van Broeckhoven, C. Epistatic effect of genes from the dopamine and serotonin systems on the temperament traits of novelty seeking and harm avoidance. Mol. Psychiat. 2002, 5, 448-450.
43. Sullivan, P.F. Spurious genetic associations. Biol. Psychiat. 2007, 10, 1121-1126.